CTMX
CytomX Therapeutics Inc
2.50$
-3.1%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.4% | -3.9% | -1.7% | -6.5% | -3.7% | -6.8% | -9.9% | -61.4% | +280.6% | -92.7% | +127.0% | – | |
| – | +108.2% | -25.3% | -1.3% | +6.0% | -5.6% | +6.6% | -28.7% | -3.3% | +6.9% | +218.2% | -45.2% | – | |
| – | – | – | – | – | – | – | – | – | – | -3,018.0% | – | – | |
| – | +2,855.6% | -56.8% | -16.5% | -80.2% | +321.1% | +48.8% | -77.3% | +370.4% | +58.3% | -100.0% | – | – | |
| – | – | +248.9% | -52.1% | -15.5% | -16.7% | +102.2% | -349.6% | – | -3,384.5% | +1,237.0% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -99.2% | -28.7% | +2,830.5% | -100.0% | – | -100.0% | – | -99.7% | +6,478.3% | +1,308.9% | -99.8% | – | |
| – | – | – | -62.9% | -136.3% | – | – | -85.0% | -1,133.8% | – | – | -171.8% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.